Nasal Spray Treatment for Depression
Unlike traditional antidepressants, Spravato supports your brain’s natural pathways.
See Why Patients Trust Us
Our goal is to build lasting partnerships with our patients.
70% Success Rate
A clinical study on patients with treatment-resistant depression found that combining an oral antidepressant with intranasal esketamine led to significant improvement. In the study, 70% of patients who received this combination showed improvement, compared to just over 50% who received a placebo
Want to learn more about Spravato treatment?
Get a free consultation with Dr. Omidvari
Spravato
As part of a treatment plan, your psychiatrist will determine if the treatment should be used alone or with an oral antidepressant. This will be done under medical supervision through the SPRAVATO® REMS program.
What We Treat with Spravato
Treatment-Resistant Depression (TRD)
Major Depressive Disorder (MDD)
Depression with Suicidal Ideation
Anxiety with Comorbid Depression
Bipolar Depression
(if applicable)
What a Session Feels Like
Personalized Care
Dr. Omidvari listens carefully to understand your unique needs, partnering with you to develop a personalized treatment plan.
Comfortable Space
Relax in a zero-gravity chair in a private, soothing room that feels nothing like a hospital.
Calm and Relaxation
With a soft eye mask and calming music, you can fully unwind as the treatment happens under close supervision.
Peace of Mind
Simply rest while we monitor you every step of the way, ensuring you feel safe and supported throughout.
Key Benefits
Fully Insurance-Covered | Prior authorization handled by our team.
Rapid System Relief | Designed for fast-acting mental clarity.
Non-Surgical & Needle-Less | A comfortable, non-invasive experience.
The Clinical Setup:
Engineered for Safety and Comfort
Our dedicated environment ensures your advanced treatment is safe, peaceful, and restorative.
All Major Insurances Accepted
We make treatment easy and accessible by providing comprehensive superbills for potential out-of-network insurance reimbursement.
Not sure if this is
the right fit for you?
Let’s connect for a quick, free phone consultation.
Spravato (esketamine). Spravato carries an FDA Boxed Warning for sedation; dissociation; potential for abuse and misuse; and suicidal thoughts and behaviors. It is a Schedule III controlled substance available only through a restricted program (Spravato REMS). Patients are monitored for at least 2 hours after each dose and must not drive until the next day after restful sleep. Common side effects include dissociation, dizziness, nausea, sedation, vertigo, anxiety, and increased blood pressure. Spravato is not right for everyone; your psychiatrist will decide if it’s appropriate.